Login / Signup

Preliminary results from a randomized, controlled, cross-over trial of intrathecal oxytocin for neuropathic pain.

James C EisenachRegina S CurryTimothy T Houle
Published in: Pain medicine (Malden, Mass.) (2023)
This study was registered at ClinicalTrials.gov on 03/27/2014 (NCT02100956). The first subject was studied on 06/25/2014.
Keyphrases
  • neuropathic pain
  • spinal cord
  • spinal cord injury
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase ii
  • phase iii